Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raab

Showing results (281-290 of 427) with videos related to

Pageof 43
Sort By:
American Journal of Clinical Pathology|May 1, 1995
Pathology and probability. Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimensS S Raab, P A Thomas, J C Lenel, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
American Journal of Clinical Pathology|November 1, 2006
Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancyStephen S Raab, Chad H Stone, Eva M Wojcik, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Cancer Research|February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myelomaKlaus Podar, Marc S Raab, Giovanni Tonon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Leukemia|May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myelomaMarc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Pageof 43

Showing results (281-290 of 427) with videos related to

Sort By:
Pageof 43
American Journal of Clinical Pathology|May 1, 1995
Pathology and probability. Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimensS S Raab, P A Thomas, J C Lenel, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
American Journal of Clinical Pathology|November 1, 2006
Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancyStephen S Raab, Chad H Stone, Eva M Wojcik, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Cancer Discovery|April 25, 2013
Targeting the BRAF V600E mutation in multiple myelomaMindaugas Andrulis, Nicola Lehners, David Capper, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Cancer Research|February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myelomaKlaus Podar, Marc S Raab, Giovanni Tonon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Leukemia|May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myelomaMarc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Pageof 43